6.
Muttillo E, Franca A, Stefanelli S, Coppola A, Li Causi F, Giannella R
. Oncological Adequacy of Laparoscopic Surgery for Bulky Gastric Cancer: Results of a Western Single-Center Series. Life (Basel). 2023; 13(12).
PMC: 10744348.
DOI: 10.3390/life13122243.
View
7.
Anania G, Chiozza M, Campagnaro A, Bagolini F, Resta G, Azzolina D
. Laparoscopic right hemicolectomy: a SICE (Società Italiana di Chirurgia Endoscopica e Nuove tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?-CoDIG 2 (ColonDx Italian Group). Surg Endosc. 2024; 38(3):1432-1441.
PMC: 10881627.
DOI: 10.1007/s00464-023-10607-8.
View
8.
Xu L, Su X, He Z, Zhang C, Lu J, Zhang G
. Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial. Lancet Oncol. 2021; 22(3):391-401.
DOI: 10.1016/S1470-2045(20)30685-9.
View
9.
Bertelsen C, Neuenschwander A, Erik Jansen J, Wilhelmsen M, Kirkegaard-Klitbo A, Tenma J
. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol. 2015; 16(2):161-8.
DOI: 10.1016/S1470-2045(14)71168-4.
View
10.
Baran B, Mert Ozupek N, Yerli Tetik N, Acar E, Bekcioglu O, Baskin Y
. Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature. Gastroenterology Res. 2018; 11(4):264-273.
PMC: 6089587.
DOI: 10.14740/gr1062w.
View
11.
Tejedor P, Francis N, Jayne D, Hohenberger W, Khan J
. Consensus statements on complete mesocolic excision for right-sided colon cancer-technical steps and training implications. Surg Endosc. 2022; 36(8):5595-5601.
PMC: 9283340.
DOI: 10.1007/s00464-021-08395-0.
View
12.
Zhao J, Wang H, Zhang Y, Wang R, Liu Q, Li J
. Deep learning radiomics model related with genomics phenotypes for lymph node metastasis prediction in colorectal cancer. Radiother Oncol. 2021; 167:195-202.
DOI: 10.1016/j.radonc.2021.12.031.
View
13.
Formica V, Sera F, Cremolini C, Riondino S, Morelli C, Arkenau H
. KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis. J Natl Cancer Inst. 2021; 114(4):517-527.
PMC: 9002292.
DOI: 10.1093/jnci/djab190.
View
14.
Huang Y, Liang C, He L, Tian J, Liang C, Chen X
. Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer. J Clin Oncol. 2016; 34(18):2157-64.
DOI: 10.1200/JCO.2015.65.9128.
View
15.
Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T
. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2019; 25(1):1-42.
PMC: 6946738.
DOI: 10.1007/s10147-019-01485-z.
View
16.
Loupakis F, Yang D, Yau L, Feng S, Cremolini C, Zhang W
. Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst. 2015; 107(3).
PMC: 4565528.
DOI: 10.1093/jnci/dju427.
View
17.
Roth A, Delorenzi M, Tejpar S, Yan P, Klingbiel D, Fiocca R
. Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. J Natl Cancer Inst. 2012; 104(21):1635-46.
DOI: 10.1093/jnci/djs427.
View
18.
Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K
. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004; 127(2):385-94.
DOI: 10.1053/j.gastro.2004.04.022.
View
19.
Gao Z, Wang C, Cui Y, Shen Z, Jiang K, Shen D
. Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial. Ann Surg. 2018; 271(3):519-526.
DOI: 10.1097/SLA.0000000000003012.
View
20.
Muttillo E, Felli E
. Can the mutational status of KRAS drive the treatment of colorectal liver metastases?. HPB (Oxford). 2021; 23(4):643.
DOI: 10.1016/j.hpb.2021.01.001.
View